$4.66
1.97% yesterday
Nasdaq, Aug 12, 10:00 pm CET
ISIN
US53228F1012
Symbol
LFST

LifeStance Health Group Inc Stock price

$4.66
+0.09 1.97% 1M
-3.20 40.71% 6M
-2.71 36.77% YTD
-0.84 15.27% 1Y
-3.54 43.17% 3Y
-17.24 78.72% 5Y
-17.24 78.72% 10Y
-17.24 78.72% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.09 1.97%

Key metrics

Basic
Market capitalization
$1.8b
Enterprise Value
$1.9b
Net debt
$151.1m
Cash
$134.3m
Shares outstanding
388.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.4 | 1.2
EV/Sales
1.5 | 1.3
EV/FCF
18.8
P/B
1.2
Financial Health
Equity Ratio
68.3%
Return on Equity
-4.0%
ROCE
-0.7%
ROIC
-0.6%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$1.3b | $1.4b
EBITDA
$49.1m | $141.0m
EBIT
$-13.4m | $1.5m
Net Income
$-35.4m | $-19.3m
Free Cash Flow
$102.5m
Growth (TTM | estimate)
Revenue
16.3% | 15.0%
EBITDA
157.0% | 256.8%
EBIT
92.1% | 104.6%
Net Income
79.6% | 66.4%
Free Cash Flow
248.9%
Margin (TTM | estimate)
Gross
-
EBITDA
3.8% | 9.8%
EBIT
-1.1%
Net
-2.8% | -1.3%
Free Cash Flow
8.0%
More
EPS
$-0.1
FCF per Share
$0.3
Short interest
9.3%
Employees
7k
Rev per Employee
$180.0k
Show more

Is LifeStance Health Group Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

LifeStance Health Group Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a LifeStance Health Group Inc forecast:

13x Buy
81%
3x Hold
19%

Analyst Opinions

16 Analysts have issued a LifeStance Health Group Inc forecast:

Buy
81%
Hold
19%

Financial data from LifeStance Health Group Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,284 1,284
16% 16%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 368 368
11% 11%
29%
- Research and Development Expense - -
-
-
49 49
157% 157%
4%
- Depreciation and Amortization 63 63
26% 26%
5%
EBIT (Operating Income) EBIT -13 -13
92% 92%
-1%
Net Profit -35 -35
80% 80%
-3%

In millions USD.

Don't miss a Thing! We will send you all news about LifeStance Health Group Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LifeStance Health Group Inc Stock News

Neutral
Seeking Alpha
5 days ago
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants David Patrick Bourdon - CEO & Director Monica Prokocki - Vice President of Investor Relations Ryan Bruce McGroarty - CFO & Treasurer Conference Call Participants Brian Gil Tanquilut - Jefferies LLC, Research Division Craig Matthew Hettenbach - Morgan Stanley, Research Div...
Positive
The Motley Fool
6 days ago
LifeStance (LFST) Q2 Revenue Jumps 11%
Neutral
GlobeNewsWire
6 days ago
SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, 2025.
More LifeStance Health Group Inc News

Company Profile

Lifestance Health Group, Inc. operates a holding company. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

Head office United States
CEO David Bourdon
Employees 6,984
Founded 2017
Website investor.lifestance.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today